Sarcomatous hepatocellular carcinoma

A special reference to ordinary hepatocellular carcinoma

Hidehiro Nishi, Ken Ichi Taguchi, Yoshiki Asayama, Shin Ichi Aishima, Keishi Sugimachi, Hajime Nawata, Masazumi Tsuneyoshi

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: Sarcomatous hepatocellular carcinoma (HCC) has a worse prognosis than ordinary HCC. The relationship between the malignant potential of sarcomatous HCC and cell proliferation or cell adhesion is unknown. This study was undertaken to clarify this relationship. Methods: In 21 cases of sarcomatous HCC, including 16 surgically resected and five autopsy cases, immunohistochemistry was used to compare the sarcomatous component (s-comp) and the ordinary component (o-comp) within each sarcomatous HCC. Results: We found 15 epithelial-cadherin (E-cadherin)-positive cases in o-comp (79%) and nine positive cases in s-comp (43%). The difference between sarcomatous HCC and ordinary HCC in E-cadherin-positive tumor prevalence was significant (P<0.05). The Ki-67 (MIB1) labeling index ratio was 127±40 in s-comp and 80±33 in o-comp, and there was a greater tendency to have an ability to multiply in s-comp than in o-comp (P=0.096). Conclusion: This study indicated that the loss of E-cadherin related to a morphological alteration in sarcomatous HCC; however, no relationship in respect to the malignant potential was found.

Original languageEnglish
Pages (from-to)415-423
Number of pages9
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume18
Issue number4
DOIs
Publication statusPublished - Apr 1 2003

Fingerprint

Hepatocellular Carcinoma
Cadherins
Cell Adhesion
Autopsy
Immunohistochemistry
Cell Proliferation
Neoplasms

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Sarcomatous hepatocellular carcinoma : A special reference to ordinary hepatocellular carcinoma. / Nishi, Hidehiro; Taguchi, Ken Ichi; Asayama, Yoshiki; Aishima, Shin Ichi; Sugimachi, Keishi; Nawata, Hajime; Tsuneyoshi, Masazumi.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 18, No. 4, 01.04.2003, p. 415-423.

Research output: Contribution to journalArticle

Nishi, Hidehiro ; Taguchi, Ken Ichi ; Asayama, Yoshiki ; Aishima, Shin Ichi ; Sugimachi, Keishi ; Nawata, Hajime ; Tsuneyoshi, Masazumi. / Sarcomatous hepatocellular carcinoma : A special reference to ordinary hepatocellular carcinoma. In: Journal of Gastroenterology and Hepatology (Australia). 2003 ; Vol. 18, No. 4. pp. 415-423.
@article{fe35e134034f4f95b985c2faf2a72186,
title = "Sarcomatous hepatocellular carcinoma: A special reference to ordinary hepatocellular carcinoma",
abstract = "Background: Sarcomatous hepatocellular carcinoma (HCC) has a worse prognosis than ordinary HCC. The relationship between the malignant potential of sarcomatous HCC and cell proliferation or cell adhesion is unknown. This study was undertaken to clarify this relationship. Methods: In 21 cases of sarcomatous HCC, including 16 surgically resected and five autopsy cases, immunohistochemistry was used to compare the sarcomatous component (s-comp) and the ordinary component (o-comp) within each sarcomatous HCC. Results: We found 15 epithelial-cadherin (E-cadherin)-positive cases in o-comp (79{\%}) and nine positive cases in s-comp (43{\%}). The difference between sarcomatous HCC and ordinary HCC in E-cadherin-positive tumor prevalence was significant (P<0.05). The Ki-67 (MIB1) labeling index ratio was 127±40 in s-comp and 80±33 in o-comp, and there was a greater tendency to have an ability to multiply in s-comp than in o-comp (P=0.096). Conclusion: This study indicated that the loss of E-cadherin related to a morphological alteration in sarcomatous HCC; however, no relationship in respect to the malignant potential was found.",
author = "Hidehiro Nishi and Taguchi, {Ken Ichi} and Yoshiki Asayama and Aishima, {Shin Ichi} and Keishi Sugimachi and Hajime Nawata and Masazumi Tsuneyoshi",
year = "2003",
month = "4",
day = "1",
doi = "10.1046/j.1440-1746.2003.02888.x",
language = "English",
volume = "18",
pages = "415--423",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Sarcomatous hepatocellular carcinoma

T2 - A special reference to ordinary hepatocellular carcinoma

AU - Nishi, Hidehiro

AU - Taguchi, Ken Ichi

AU - Asayama, Yoshiki

AU - Aishima, Shin Ichi

AU - Sugimachi, Keishi

AU - Nawata, Hajime

AU - Tsuneyoshi, Masazumi

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Background: Sarcomatous hepatocellular carcinoma (HCC) has a worse prognosis than ordinary HCC. The relationship between the malignant potential of sarcomatous HCC and cell proliferation or cell adhesion is unknown. This study was undertaken to clarify this relationship. Methods: In 21 cases of sarcomatous HCC, including 16 surgically resected and five autopsy cases, immunohistochemistry was used to compare the sarcomatous component (s-comp) and the ordinary component (o-comp) within each sarcomatous HCC. Results: We found 15 epithelial-cadherin (E-cadherin)-positive cases in o-comp (79%) and nine positive cases in s-comp (43%). The difference between sarcomatous HCC and ordinary HCC in E-cadherin-positive tumor prevalence was significant (P<0.05). The Ki-67 (MIB1) labeling index ratio was 127±40 in s-comp and 80±33 in o-comp, and there was a greater tendency to have an ability to multiply in s-comp than in o-comp (P=0.096). Conclusion: This study indicated that the loss of E-cadherin related to a morphological alteration in sarcomatous HCC; however, no relationship in respect to the malignant potential was found.

AB - Background: Sarcomatous hepatocellular carcinoma (HCC) has a worse prognosis than ordinary HCC. The relationship between the malignant potential of sarcomatous HCC and cell proliferation or cell adhesion is unknown. This study was undertaken to clarify this relationship. Methods: In 21 cases of sarcomatous HCC, including 16 surgically resected and five autopsy cases, immunohistochemistry was used to compare the sarcomatous component (s-comp) and the ordinary component (o-comp) within each sarcomatous HCC. Results: We found 15 epithelial-cadherin (E-cadherin)-positive cases in o-comp (79%) and nine positive cases in s-comp (43%). The difference between sarcomatous HCC and ordinary HCC in E-cadherin-positive tumor prevalence was significant (P<0.05). The Ki-67 (MIB1) labeling index ratio was 127±40 in s-comp and 80±33 in o-comp, and there was a greater tendency to have an ability to multiply in s-comp than in o-comp (P=0.096). Conclusion: This study indicated that the loss of E-cadherin related to a morphological alteration in sarcomatous HCC; however, no relationship in respect to the malignant potential was found.

UR - http://www.scopus.com/inward/record.url?scp=0038218491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038218491&partnerID=8YFLogxK

U2 - 10.1046/j.1440-1746.2003.02888.x

DO - 10.1046/j.1440-1746.2003.02888.x

M3 - Article

VL - 18

SP - 415

EP - 423

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 4

ER -